Monday, November 18, 2024
- 10:30AM-12:30PM
-
Abstract Number: 2458
Risk Factors for Progression of Interstitial Lung Disease in Patients with Early Diffuse Cutaneous Systemic Sclerosis
Systemic Sclerosis & Related Disorders – Clinical Poster III- 10:30AM-12:30PM
-
Abstract Number: 2261
Risk of Cervical Intraepithelial Neoplasia During Janus Kinase (JAK) Inhibitor Treatment in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study
RA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2009
Risk of Incident Gout and Cardiovascular Events Within 120 Days of Incident Gout with the Use of Insulin Glargine, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Veterans with Type 2 Diabetes
Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster III- 10:30AM-12:30PM
-
Abstract Number: 1867
RNA Polymerase III Specific CD8+ T Cells at the Interface Between Scleroderma and Cancer
T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster- 10:30AM-12:30PM
-
Abstract Number: 2225
Role of Fatigue in Difficult to Treat Rheumatoid Arthritis
RA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2131
Role of LECT2 in the Regulation of Bone Metabolism In Vitro and In Vivo
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 10:30AM-12:30PM
-
Abstract Number: 1831
Role of Long Non-Coding RNA H19 in Mediating Skin Fibrosis in Systemic Sclerosis
Systemic Sclerosis & Related Disorders – Basic Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 2052
Role of Scleroderma/myositis-related Autoantibodies Detected by Immunoblot to the Diagnosis of Systemic Autoimmune Rheumatic Diseases in 410 Patients from a Single Referral Center
Miscellaneous Rheumatic & Inflammatory Diseases Poster III- 10:30AM-12:30PM
-
Abstract Number: 1864
S-4321, a Novel Dual-cell Bidirectional PD-1:FcγRIIb Selective Agonist Antibody for the Treatment of Autoimmune Disease
T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster- 10:30AM-12:30PM
-
Abstract Number: 1979
Safety and Effectiveness of Immune Checkpoint Inhibitor Therapy in Patients with Pre-existing Autoimmune Disease
Immunological Complications of Medical Therapy Poster- 10:30AM-12:30PM
-
Abstract Number: 2246
Safety and Efficacy of Cannabidiol in Rheumatoid Arthritis Patients: A Phase 1B Pilot Randomized Placebo Controlled Trial
RA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2019
Safety and Efficacy of SEL-212 in the US and ex-US Subgroups: Results from the Phase 3 DISSOLVE Studies
Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster III- 10:30AM-12:30PM
-
Abstract Number: 2285
Safety and Tolerability of a Combination of Curcumin, Omega-3 and Vitamin-D: Results from the PASCOD Study, an RA Prevention Protocol